Remove tag turning-point-therapeutics
article thumbnail

Almirall and IRB Barcelona team up to tackle skin disease

pharmaphorum

The use of monovalent degraders, which enable the targeted degradation of disease-relevant proteins, offers a new avenue to reach tissue that cannot be targeted with conventional therapeutic agents. Researchers at Almirall have identified several proteins whose abnormal function is associated with inflammatory immune skin diseases.

article thumbnail

Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court

Pharmaceutical Technology

Both drugs come with a high price tag. Amgen’s point is that the law does not require patent applications to include thousands of examples if the patent claim covers thousands of chemical entities or antibodies, says Falati. Recently, the Federal Circuit turned to the full scope approach in its enablement requirements, says Falati.

FDA 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Addressing Cultural Competency: Healthcare for Refugees & Minority Populations

Colors Make me Happy

Fatima, mother of eleven children, had watched as her town in northern Kurdistan was turned from a small river community into a combat zone. From my experience, patients may seek urgent care simply because they want to share their trauma with another human and be heard, a form of therapeutic treatment in itself.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication.